Tablet-Breaking Ability of Older Persons With Type 2 Diabetes Mellitus

The Diabetes Educator

Volumn 27, Issue 4, 2001, Pages 530-540

  Wilson, Margaret Mary G ^a,b   Kaiser, Fran E ^a   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GENERIC DRUG;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; TABLET;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DRUGS, GENERIC; HUMANS; HYPOGLYCEMIC AGENTS; PSYCHOMOTOR PERFORMANCE; TABLETS;

EID: 0035411801     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572170102700408     Document Type: Article

References (33)

1. Ratner RE. Type 2 diabetes mellitus: the grand overview. Diabetic Med. 1998;15(suppl 4):S4-S7.
2. Morley JE. An overview of diabetes mellitus in older persons. Clin Geriatr Med. 1999;15:211-224.
3. Harris M. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med. 1990;6:703-719.
4. Herman WH, Dasbach EJ, Songer TJ, Eastman RC. The cost-effectiveness of intensive therapy for diabetes mellitus. Endocrinol Metab Clin North Am. 1997;26:679-695.
5. Cramer JA. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging. 1998;12:7-15.
6. Raynor DK, Booth TG, Blenkinsopp A. Effects of computer generated reminder charts on patients’ compliance with drug regimens. BMJ. 1993; 306:1158-1161.
7. Simmons D, Upjohn M, Gamble GD. Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized control trial. Diabetes Care. 2000;23:153-156.
8. Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Aging. 1994;23:113-116.
9. Lundqvist AK, Podczeck F, Newton JM. Influence of disintegrant type and proportion of tablets produced from mixtures of pellets. Int J Pharmaceutics. 1997;147:95-107.
10. Stimpel M, Vetter H., Kuffer B, et al. The scored tablet—a source of error in drug dosing? J Hypertens. 1985;3:S97-S99.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
12. Morisaki N, Watanabe S, Kobayashi J. Diabetic control and progression of retinopathy in elderly patients: 5-year follow-up study. J Am Geriatr Soc. 1994;42:142-145.
13. Qiao Q, Keinanen-Kiukaanniemi S, Laara E. The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol. 1997;50:153-158.
14. Singh I, Marshall MC. Diabetes mellitus in the elderly. Endocrinol Metab Clin. 1995;24:255-272.
15. Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic peripheral neuropathy: effect of glucose on pain perception in humans. Am J Med. 1984;77: 79-82.
16. Strachan MW, Deary IJ, Ewing FM, et al. Is type 2 diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care. 1997;20:438-445.
17. Brodows RG. Benefits and risk with glyburide and glipizide in elderly NIDDM patients. Diabetes Care. 1992;15:75-80.
18. Rosenstock J, Carrao PJ, Goldberg RB, Kito C. Diabetes control in the elderly: a randomized comparative study of glyburide versus glipizide in non insulin dependent diabetes mellitus. Clin Ther. 1993;15: 1031-1040.
19. Noges MA, Carter BL, Helling DK, McCormick WC, Ramirez R. Evaluation of glipizide and glyburide in a health maintenance organization. Ann Pharmacother. 1992;26:1215-1220.
20. McLane CG, Zyzanski SJ, Flocke SA. Factors associated with medication noncompliance in rural elderly antihypertensive patients. Am J Hypertens. 1995;8:206-209.
21. Cline CM, Biorck-Linne AK, Israelsson BY, Willenheimer RB, Eihardt LR. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Failure. 1999;1:145-149.
22. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Non-compliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994;154:433-437.
23. Nelson KM, Talbert RL. Drug related hospital admissions. Pharmacotherapy. 1996;16:701-707.
24. Ogle SJ, Finnegan TP, Shenfield G, Atkin P. An evaluation of adverse drug reactions contributing to hospital admissions in a geriatric population. Aust N Z J Med. 1990;20(suppl 1):381-381.
25. Stradberg LR. Drugs as a reason for nursing home admission. J Am Health Care Assoc. 1984;10:20-22.
26. Hurd PD, Butkovich SL. Compliance problems and the older patient: assessing functional limitations. Drug Intell Clin Pharm. 1986;20: 228-231.
27. Chammas M, Bousquet P, Renard E, Poirer J, Jaffiol C, Allieu Y. Dupuytren's disease, carpal tunnel syndrome, trigger finger and diabetes mellitus. J Hand Surgery. 1995;20A:109-114.
28. Casanova JE, Casanova JS, Young MJ. Hand function in patients with diabetes mellitus. South Med J. 1991;84:1111-1113.
29. Rivers PH. Compliance aids: do they work? Drugs Aging. 1992;2:103-111.
30. Murray MD, Birt JA, Manatunge AK, et al. Medication compliance in elderly outpatients using twice-daily and unit-of-use packaging. Ann Pharmacother. 1993;27: 616-621.
31. Gupta P, Gupta K. Does the sum of the parts equal the whole? Am J Hosp Pharm. 1988;45:1498-1498.
32. Kristensen HG, Jorgensen GH, Moller-Sonnergard. Mass uniformity of tablets broken by hand. Pharmeuropa. 1995;7: 298-302.
33. Miller DK, Morley JE. Nutritional epidemiology. In: Morley JE, Miller DK, Powell Lawton M, eds. Annual Review of Geriatrics and Gerontology. New York: Spinger Publishing;1995:20-53.